Marble City India Allots 30 Lakh Warrants to Promoters

Marble City India has allotted 30,00,000 convertible warrants at Rs 100 per unit to promoters Saket Dalmia and Amit Dalmia.
The company has successfully collected the mandatory 25% upfront subscription amount of Rs 25 per warrant.

Reader Takeaway: Promoter commitment is signaled through capital infusion, though existing shareholders face future dilution upon warrant conversion.

What just happened

Marble City India completed the allotment of 30 lakh convertible warrants to promoters Saket Dalmia and Amit Dalmia, with each receiving 15 lakh warrants. Each warrant is priced at Rs 100, including a premium of Rs 95. The company received the mandatory 25% subscription payment, confirming compliance with SEBI (ICDR) regulations.

Why this matters

This transaction serves as a capital infusion mechanism for the company. While the paid-up share capital remains unchanged today, the conversion of these warrants into equity shares within the next 18 months will eventually increase the total equity base. The move reflects confidence from the promoter group in the company’s future prospects.

The backstory

The allotment follows approval granted by shareholders during the Extra Ordinary General Meeting (EGM) held on June 10, 2026. Furthermore, the company secured in-principle approval from the BSE for the issuance under Letter No. LOD/PREF/MV/FIP/761/2026-27 dated September 9, 2026.

What changes now

The company has received the initial 25% capital influx. Holders now have an 18-month window to exercise their conversion option into equity shares of face value Rs 5 each, subject to the payment of the remaining 75% of the issue price. The shares issued upon conversion will be subject to statutory lock-in periods as mandated by market regulators.

Risks to watch

Investors should monitor the potential dilution of earnings per share (EPS) that will occur once these warrants are converted into equity. Additionally, the execution of the conversion depends on the promoters exercising their option within the 18-month tenure.

What to track next

Shareholders should track future regulatory filings regarding the conversion exercise dates and any subsequent changes to the company's equity capital structure.